Fingerprint
Dive into the research topics of 'Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL+ leukemia cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL+ leukemia cells
Tri Nguyen, Elisa Hawkins, Akhil Kolluri, Maciej Kmieciak, Haeseong Park, Hui Lin, Steven Grant
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations